CA - Aurinia Pharma GAAP EPS of -$0.07 beats by $0.07 revenue of $50.3M beats by $3.23M
2024-05-02 06:09:37 ET
More on Aurinia Pharma
- Aurinia: Updated Lupkynis Label Should Keep Sales Growth Momentum Going
- Aurinia Pharmaceuticals: Potential For Significant Upside By Year-End 2024
- Aurinia Pharma: Cheaper Now, But Buyout Hopes Dashed
- Aurinia Pharma Q1 2024 Earnings Preview
- Aurinia gains on Lupkynis label update